Biomarker hub·longevity
Aging
Men Women (soon)

Biological Age

Biological age is an attempt to put a single number on how worn-down (or well-preserved) your physiology is, independent of birthdays. Composite estimates such as PhenoAge and BioAge fold routine bloodwork into one age-equivalent figure; epigenetic clocks do the same from DNA methylation. The point is never the absolute number, but the delta against chronological age and how that delta moves under intervention.

Optimal range
Range varies by individual.
Test frequency
Annually for routine tracking; every six months during an active intervention (new training block, weight loss, supplement protocol) where you want to see whether the work is bending the curve.
When to measure
Measure when you start any structured longevity protocol so you have a baseline, then re-measure every six to twelve months. Time it alongside your annual lipid and metabolic panel so the same blood draw feeds both calculations. Avoid measuring during acute illness, after a recent surgery, or within two weeks of an intense training block, CRP and lymphocyte shifts will skew the estimate transiently and misrepresent your steady-state biology.
How to measure
PhenoAge and BioAge calculations need a standard lipid panel, comprehensive metabolic panel, and CBC with differential, roughly $40–$80 retail in the US, often free if ordered with your annual physical. Plug the values into a free online calculator (Aging.AI, Levine PhenoAge spreadsheet). For epigenetic clocks, see the epigenetic-age page; the methylation tests run $200–$500 and require a saliva or blood spot sample sent to TruDiagnostic, Elysium, or similar labs.

Why this biomarker matters

A biological age several years below chronological age associates with lower all-cause mortality, fewer cardiovascular events, and lower cancer incidence in long-running cohorts. PhenoAge in particular, derived from nine routine labs (albumin, creatinine, glucose, CRP, lymphocyte percent, mean cell volume, red cell distribution width, alkaline phosphatase, white blood count), has been validated against decades of NHANES mortality follow-up. The clinical value is not the absolute estimate; it is the response to intervention. Caloric restriction, structured exercise, improved sleep, and a handful of pharmacologic agents (metformin, rapamycin in animal models, possibly GLP-1 agonists) all appear to slow or reverse PhenoAge in observational and small interventional studies. Tracking biological age every six to twelve months turns a soft "health" goal into a number that either moves or does not, and that makes it a useful long-term anchor for any longevity protocol.

The prime report

Weekly performance intelligence.

New studies, protocols, and optimization frameworks delivered every Monday. No fluff, no motivation quotes — only what moves the needle.

No spam. Unsubscribe anytime.

Listen